SCHEMBL5755833

SCHEMBL5755833

O=c1[nH]c(=O)n(CC2CCC2)c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
CYP3A4 P08684 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
JAK3 P52333 1/20 0.40
MTOR P42345 11/20 0.37
HPGD P15428 1/20 0.37
GRIN1 Q05586 2/20 0.35
GRIN2B Q13224 2/20 0.35
PIK3CA P42336 1/20 0.35
MAPK9 P45984 1/20 0.35
PDE5A O76074 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27338541 0.79 MEN1 (0.36) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL27319971 0.76 ALDH1A1 (0.42) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL16880352 0.72 SMN1; SMN2 (0.58) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL464610 0.72 SMN1; SMN2 (0.58) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL13451946 0.71 HPGD (0.47) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL2212148 0.70 MTOR (0.57) MTORPIK3CA
SCHEMBL30799027 0.69 ALDH1A1 (0.45) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL10735070 0.69 KMT2A (0.85) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL12035535 0.69 CHRM5 (0.46) ALDH1A1SMN1; SMN2PDE5APDE4APDE4B
SCHEMBL31258998 0.68 MAPK9 (0.52) ALDH1A1MEN1CYP3A4KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412338-B1 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES INC (US) 2006-01-18 EP disclosed
EP-1412338-A1 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS Neurocrine Biosciences, Inc. (US) 2004-04-28 EP disclosed
WO-2003011839-A1 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 2003-02-13 WO disclosed